Clinical trials
Diabetes Mellitus clinical trials
Below are recruiting diabetes mellitus clinical trials, each written for real people, not researchers. We’re tracking 887 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07372872Recruiting
App for managing gestational diabetes
This study tests a smartphone app called MyGlucoCare to help women with gestational diabetes manage their condition. If you are pregnant and have been diagnosed with gestational diabetes, you may be able to join.
Hong KongAges 18 years+ - NCT07374328RecruitingPhase 1/Phase 2
Three diabetes medicines for new type 2 diabetes
This trial tests a combination of three diabetes medicines to see if they can quickly get high blood sugar under control in people newly diagnosed with type 2 diabetes. It's designed for those whose HbA1c is 9.0% or higher.
Guangzhou, GuangdongAges 18–65 - NCT02420470Recruiting
An early warning system for diabetic brain changes
This study tests whether an “early warning” approach can detect early changes in the brain related to diabetes before serious problems happen. If you qualify, you may be asked to take part in brain and health assessments to see how well the system works.
Xi'an, ShaanxiAges 40–65 - NCT07463859Recruiting
Treating gum disease and bad breath in diabetes patients
This trial tests whether combining standard gum treatment with a light-activated therapy can reduce bad breath in people with type 2 diabetes and advanced gum disease.
Bauru, São PauloAges 18–70 - NCT07491185Recruiting
How blood sugar control affects brain oxygen and recovery in diabetic surgery patients
This study looks at how well-controlled blood sugar (measured by HbA1c) affects brain oxygen levels during urologic surgery and how it impacts recovery afterward. It compares diabetic patients to non-diabetic patients to understand the role of blood sugar control in surgical outcomes.
IzmirAges 18 years+ - NCT07536516Recruiting
Eye Blood Flow Study in Diabetes Patients Starting New Medication
This study measures blood flow in the eyes and how the retina (back of the eye) uses oxygen in people with diabetes who are starting a new type of diabetes medication. Researchers want to understand how these newer medications affect blood vessels in the eyes.
Vienna, State of ViennaAges 18 years+ - NCT06960408Enrolling by invitation
Sleep, relaxation, and diabetes: A study on reducing anxiety
This study tests whether learning about good sleep habits and practicing a simple relaxation technique can help people with diabetes sleep better, feel less anxious, and improve blood sugar control.
AnkaraAges 18–64 - NCT06924697Enrolling by invitation
Testing a diabetes drug to help men quit smoking
This study tests if a medication used for type 2 diabetes (GLP-1 receptor agonists) can also reduce smoking in men with diabetes who smoke. If you qualify, you may receive this drug or a standard diabetes pill to see if it helps you smoke less.
Shanghai, Shanghai MunicipalityAges 18–75 - NCT06645223Enrolling by invitation
Gut bacteria and pancreas function in diabetes
This study looks at how gut bacteria relate to the pancreas's ability to make insulin in people with different blood sugar levels. It may help researchers understand why some people develop diabetes and how to better treat it.
BeijingAges 18–80 - NCT05915260Enrolling by invitation
Heart MRI study in adults with type 2 diabetes
This study uses a heart scan (MRI) to learn more about how the heart is affected in people with type 2 diabetes. It may help researchers better understand changes in the heart over time and who might benefit from future care.
SlagelseAges 18–80 - NCT07463209Recruiting
Diabetes education with continuous glucose monitoring for older adults
This study tests whether adding continuous glucose monitoring (CGM) to diabetes education helps older adults with diabetes manage their blood sugar better. You and a care partner will learn how to use CGM and support each other.
Chapel Hill, North CarolinaAges 65 years+ - NCT06469593Recruiting
Automated insulin delivery for type 1 diabetes study
This study tests a new automated insulin delivery (AID) system that connects your insulin pump to your glucose monitor to help keep your blood sugar in range. It is for both children and adults with type 1 diabetes who have not used an AID system before.
Herlev, Greater CopenhagenAges 7 years+ - NCT07287943Recruiting
Medtronic pump study for diabetes and gastroparesis
This study tests whether the Medtronic 780G insulin pump helps people with type 1 diabetes and gastroparesis (slowed stomach emptying) control their blood sugar better than their usual care. It requires continuous glucose monitoring and certain blood sugar levels.
Indianapolis, IndianaAges 18 years+ - NCT07356089Recruiting
Twiist insulin pump study for type 1 diabetes
This study follows people with type 1 diabetes who are already using the Twiist automated insulin delivery system. Researchers will ask you to complete surveys and share data for 12 months to check how well the system works in everyday life.
Tampa, FloridaAges 6 years+ - NCT07248891Enrolling by invitation
Type 2 diabetes study in Mexico
This study looks at factors related to type 2 diabetes in adults receiving care at family medicine clinics in three Mexican states. It may help improve understanding of diabetes management.
Mexico City, Mexico CityAges 18 years+ - NCT07054125Recruiting
CGM, education, and peer support for type 2 diabetes
This trial tests if using a continuous glucose monitor (a small sensor that tracks your blood sugar), combined with diabetes education and support from others with diabetes, can help people with type 2 diabetes better control their blood sugar. You may qualify if your blood sugar is not well controlled (A1c above 8%).
Asheville, North CarolinaAges 18 years+ - NCT07211126Recruiting
Control-IQ Study: Quality of Life with Type 1 Diabetes in France
This real-world study looks at how the Control-IQ system (an automated insulin pump with a continuous glucose monitor) affects blood sugar control and quality of life for people with type 1 diabetes in France. If you join, you will use the system as usual and fill out some questionnaires for one year.
AgenAges 6 years+ - NCT05472441Recruiting
Linking food support and education to improve type 2 diabetes care
This study tests whether adding diabetes education, food support, and community referrals can help people with type 2 diabetes manage their health. You may be eligible if your diabetes is not well controlled and you may be facing food insecurity.
Columbus, OhioAges 18 years+ - NCT05415878Recruiting
Comparing removable boot designs for diabetic foot ulcers
This study compares different removable cast walkers (special boots) to see which is easier for people with diabetic foot ulcers to use. If you join, you'll try one of these boots and share your experience, which may help heal your ulcer while keeping you mobile.
North Chicago, IllinoisAges 18 years+ - NCT05762107RecruitingPhase 2
Drug ZT-01 to reduce low blood sugar at night
This Phase 2 study tests ZT-01 to help prevent night-time low blood sugar (hypoglycemia) in people with type 1 diabetes. It may help if you’ve had low blood sugar during sleep or are at high risk based on recent glucose monitoring.
Birmingham, AlabamaAges 18–75 - NCT07606872Enrolling by invitation
Testing a diabetes score to guide treatment reversal
This study tests a new scoring system to help people with type 2 diabetes understand their condition better and potentially reverse or improve it. You'll use a digital platform to track blood sugar, answer health questions, and have blood tests to see if the system helps guide your treatment plan.
Manchester, EnglandAges 18 years+ - NCT07224321RecruitingPhase 2
Inhaled insulin for youth with newly diagnosed type 1 diabetes
This study tests an inhaled insulin called Afrezza for teenagers and children who have just been diagnosed with type 1 diabetes. It aims to see if this new way of taking insulin can help manage blood sugar and fit into their lives.
Los Angeles, CaliforniaAges 6–17 - NCT07533604Recruiting
Using a smartphone app and glucose monitor for type 2 diabetes
This 8-week study tests whether using a smartphone app called SnapD along with a continuous glucose monitor (a small sensor that tracks your blood sugar throughout the day) helps people with type 2 diabetes manage their condition better. You'll keep taking your current diabetes medications without changes.
Bangkok, BangkokAges 18–65 - NCT07088068RecruitingPhase 3
Teplizumab for newly diagnosed type 1 diabetes
This study tests whether teplizumab can help keep the body making insulin in people recently diagnosed with type 1 diabetes. It is for children and young adults aged 1 to 25, and compares the drug against a placebo.
Scottsdale, ArizonaAges 1–25
Hear when a new Diabetes Mellitus trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for diabetes mellitus?
- Yes. Clin2 currently lists 887 recruiting diabetes mellitus studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a diabetes mellitus trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a diabetes mellitus trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.